BMP4 overexpression induces the upregulation of APP/Tau and memory deficits in Alzheimer’s disease
Abstract Alzheimer’s disease (AD) is a chronic progressive degenerative disease of the nervous system. Its pathogenesis is complex and is related to the abnormal expression of the amyloid β (Aβ), APP, and Tau proteins. Evidence has demonstrated that bone morphogenetic protein 4 (BMP4) is highly expr...
Main Authors: | Xiaoqing Zhang, Juan Li, Li Ma, Hui Xu, Yun Cao, Wei Liang, Jia Ma, Z. Peter Wang, Yuyun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-021-00435-x |
Similar Items
-
CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease
by: Yang-Ping Shentu, et al.
Published: (2018-07-01) -
DNA vaccines targeting amyloid-β oligomer ameliorate cognitive deficits of aged APP/PS1/tau triple-transgenic mouse models of Alzheimer’s disease
by: Sha Sha, et al.
Published: (2022-01-01) -
Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer’s disease
by: Yun Yang, et al.
Published: (2022-01-01) -
Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles.
by: Jin Chu, et al.
Published: (2013-01-01) -
Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease
by: Huiqin Zhang, et al.
Published: (2021-07-01)